AuntMinnie

JULY 11, 2023

Pharmaceutical industry companies were involved in payments to diagnostic radiolog.

Diagnostic 100

Diagnostic Radiation Oncology Pharmaceutical Radiology 100

AuntMinnie

SEPTEMBER 18, 2024

Telix Pharmaceuticals has selected Cardinal Health to distribute its PET agent TLX250-CDx (Zircaix) for imaging kidney cancer in the U.S., subject to its regulatory approval. In a recent phase III trial , the radiotracer was shown to be safe and effective for identifying small lesions, which could allow for earlier diagnosis of the disease.

Pharmaceutical 147

Pharmaceutical Disease Diagnostic IT 147

Imaging Technology

JULY 9, 2024

Campione also joins the Blue Earth Diagnostics Ltd. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Board of Directors.

Diagnostic 105

Diagnostic Radiopharmaceuticals Nuclear Medicine Magnetic Resonance Imaging 105

AuntMinnie

OCTOBER 30, 2024

GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its Pharmaceutical Diagnostics segment. For the period (end-September 30), GEHC had total revenues of $4.86 billion, flat compared with $4.82 last year to 16.3%

Healthcare 130

Healthcare Healthcare Pharmaceutical Ultrasound 130

AuntMinnie

JULY 31, 2024

The company’s Pharmaceutical Diagnostics segment generated $639 million in second-quarter revenues, a 14% increase on an organic basis over last year, GE HealthCare reported. Pharmaceutical Diagnostics segment EBIT was $200 million, up 31% over last year.

Healthcare 130

Healthcare Healthcare Pharmaceutical Ultrasound 130

AuntMinnie

FEBRUARY 13, 2025

billion, which the company attributed to advanced visualization solutions (AVS) and pharmaceutical diagnostics, with overall strength in the U.S. The company for the fourth quarter posted 2% year-over-year growth and organic revenue growth of 2%. Revenue for the quarter came to $5.3 Total revenue for the fiscal year came out to $19.7

Healthcare 130

Healthcare Healthcare Pharmaceutical Diagnostic 130

AuntMinnie

DECEMBER 18, 2024

Shuttle Pharmaceuticals Holdings has entered a sponsored research agreement with the University of California, San Francisco (UCSF) to develop Shuttle's ligand to the prostate-specific membrane antigen (PSMA) as a theranostic molecule.

Pharmaceutical 130

Pharmaceutical Diagnostic IT 130

AuntMinnie

FEBRUARY 19, 2025

Clarity Pharmaceuticals has secured fast-track designation from the U.S. The classification builds on Clarity's earlier receipt of fast-track designation for its PET diagnostic imaging agent Cu-64 SAR-bisPSMA for identifying patients with the disease.

Radiopharmaceuticals 130

Radiopharmaceuticals Pharmaceutical Disease Diagnostic Imaging 130

AuntMinnie

OCTOBER 25, 2023

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, and PSI CRO, a global contract research organization, plan to conduct a trial using Clarity's phase III diagnostic trial of Clarify for prostate cancer patients.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Diagnostic Clinic 130

AuntMinnie

MARCH 5, 2024

Telix Pharmaceuticals has entered an agreement to acquire Canadian diagnostic imaging isotopes company ARTMS for $82 million. Under the agreement, Telix will take on ARTMS’ cyclotron-based isotope production platform, manufacturing plant, and stockpile of ultrapure rare metals such as zinc-68, which is irradiated to produce gallium-68.

Pharmaceutical 130

Pharmaceutical Diagnostic Imaging Diagnostic Imaging 130

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

Nuclear Medicine 264

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 264

AuntMinnie

MARCH 14, 2024

Clarity Pharmaceuticals has completed its third cohort in the theranostic SECuRE trial evaluating copper-64 (Cu-64) and copper-67 (Cu-67) sarcophagine chelator technology in patients with metastatic castration-resistant prostate cancer.

Pharmaceutical 130

Pharmaceutical Diagnostic Radiation Oncology IT 130

Imaging Technology

JUNE 21, 2023

milla1cf Wed, 06/21/2023 - 19:47 June 21, 2023 — Fresenius Kabi , a leading provider of injectable medicines, announced today it has launched the diagnostic pharmaceutical agent, Sincalide for Injection, an authorized generic for Bracco Diagnostics Inc. ’s s Kinevac (Sincalide for Injection) product.

IT 98

IT Pharmaceutical Radiology X-ray 98

AuntMinnie

SEPTEMBER 22, 2024

Telix Pharmaceuticals has inked a deal to acquire Florida-based radiopharmacy network RLS Radiopharmacies for up to $250 million, the companies announced. RLS Radiopharmacies is the third-largest radiopharmacy network in the U.S. said Telix Managing Director and Group Chief Executive Officer Christian Behrenbruch, MD, in a news release.

Radiopharmaceuticals 130

Radiopharmaceuticals Pharmaceutical Diagnostic IT 130

AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. At the time, their cancer center served a significant cancer population in the region and maintained robust and ever-expanding PET diagnostics.

Nuclear Medicine 264

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 264

Imaging Technology

OCTOBER 11, 2023

based company, to develop, manufacture and commercialize SOFIE’s Gallium-68 and Fluorine-18 labelled diagnostics targeting fibroblast activation protein (FAP). milla1cf Wed, 10/11/2023 - 13:24 October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based

Healthcare 105

Healthcare Healthcare Pharmaceutical Radiopharmaceuticals 105

Imaging Technology

JUNE 15, 2023

For pharmaceutical companies and researchers, using this tracer to better understand the mechanism of action - i.e. the effect of immunotherapies on a patient’s immune response to their cancer - could, potentially, enable them to better select patients to participate in clinical trials and bring new immunotherapies to market.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 98

AuntMinnie

APRIL 22, 2024

For CT and MRI procedures where injected contrast media is ordered, ".

Radiology Technologist 264

Radiology Technologist Medicare Radiologist Basic Life Support 264

Imaging Technology

JULY 24, 2024

Not for use in diagnostic procedures. “We The company noted it recently released findings from a study conducted with Quest Diagnostics, a leading provider of diagnostic information services, on the impact of its AI-enabled workflows. Concentriq AP is for research use only.

DICOM 115

DICOM Pharmaceutical Diagnostic Disease 115

AuntMinnie

DECEMBER 1, 2023

With Caption Guidance, even healthcare providers without specialized training or experience can perform cardiac ultrasound exams and acquire diagnostic-quality cardiac images, according to the vendor.

Healthcare 246

Healthcare Healthcare X-ray Ultrasound 246

Imaging Technology

JULY 25, 2024

Medical isotopes are essential for a wide range of diagnostic and therapeutic procedures, including cancer treatments and advanced imaging techniques. An active DMF enables clinical investigators or pharmaceutical companies to reference the filing in their regulatory submissions. a subsidiary of BWX Technologies, Inc.

Medical 105

Medical Radiopharmaceuticals Pharmaceutical Clinic 105

Imaging Technology

JANUARY 21, 2025

The project is the second funded and supported by NEURii, a global collaboration between the pharmaceutical company Eisai, Gates Ventures, the University of Edinburgh, the medical research charity LifeArc and the national health data science institute Health Data Research UK.

Pharmaceutical 59

Pharmaceutical Public Health Disease Diagnose 59

Diagnostic Imaging

JULY 5, 2023

The prospective multicenter trial, which is slated to begin patient recruitment in late 2023, will reportedly assess the ability of 64Cu SAR-bisPSMA to diagnose prostate cancer within pelvic lymph nodes.

Pharmaceutical 59

Pharmaceutical Diagnose 59

Imaging Technology

APRIL 24, 2023

In this new position, he brings more than 20 years of operational and leadership expertise in the pharmaceutical and life sciences industry to the Company. Previous to Catalent, he was Managing Director, North America, with SEQENS CDMO, a global leader in pharmaceutical solutions (CDMO, Generic APIs).

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Government 98

Imaging Technology

MAY 25, 2023

Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. In the U.S.,

Clinic 94

Clinic Healthcare Healthcare Imaging 94

AuntMinnie

JUNE 14, 2024

The recent FDA approval of Madrigal Pharmaceuticals' Rezdiffra (resmetirom) medication marks a significant milestone in the adoption of medical imaging for identifying and monitoring patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe progression, metabolic dysfunction-associated steatohepatitis (MASH). (..)

Imaging 130

Imaging Imaging Modalities Disease Medical Imaging 130

AuntMinnie

AUGUST 5, 2024

Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. Diagnostic and Interventional Radiology , December 2006, Vol. In a worst-case scenario, gadolinium-based contrast agents could wind up in the same unenviable position as other pharmaceuticals. "I Giles, U.K.

Disease 290

Disease MRI Radiologist X-ray 290

Imaging Technology

FEBRUARY 12, 2024

Proscia’s Concentriq AP-Dx is a comprehensive diagnostic software solution that immerses pathologists in an intuitive experience for viewing, interpreting, and managing whole slide images and helps to drive confidence and efficiency gains. Reference: 1. NHS England (2017).

Pharmaceutical 105

Pharmaceutical Clinic Diagnostic IT 105

Imaging Technology

APRIL 3, 2023

produced, non-uranium based Mo-99 for use in diagnostic imaging. RadioGenix Systems have generated almost two million doses of Tc-99m for patients’ diagnostic imaging studies to date, with utilization continuing to steadily increase. Our track record of success includes our program to supply U.S.-produced, Additional n.c.a.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

AuntMinnie

OCTOBER 11, 2024

The recommendation was issued by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA), the primary body in the European Union responsible for regulating pharmaceuticals. The agent is used at a low dose for MRI liver scans and "meets an important diagnostic need in patients with few alternatives."

MRI 147

MRI Radiologist Diagnostic Pharmaceutical 147

Imaging Technology

MARCH 21, 2024

christine.book Thu, 03/21/2024 - 10:34 March 21, 2024 — Diagnostic imaging provider US Radiology Specialists has announced that Lee Cooper will become its new Chief Executive Officer (CEO), and that current board member Molly Joseph will become its next Board Chair. Cooper and Joseph will succeed John Perkins , U.S.

Healthcare 103

Healthcare Healthcare Radiology Government 103

Imaging Technology

JULY 25, 2023

RTX-1363S has the potential to transform the way we detect and monitor various epithelial-derived cancers." "We are delighted by our collaboration with Ratio Therapeutics in advancing the clinical development of RTX-1363S as a FAP-targeted diagnostic to the clinic," stated Etienne Montagut , Lantheus' Chief Business Officer. "By

Radiopharmaceuticals 98

Radiopharmaceuticals Imaging Pharmaceutical Disease 98

MRI Network

MARCH 25, 2024

Big data has become a pillar in modern pharmaceutical practices. Pharmaceutical companies have also leveraged big data in third-party collaborations, resulting in more efficient product deployment and customer experiences. Industry experts predict the pharmaceutical analytical testing market could total an estimated USD 8.98

Pharmaceutical 59

Pharmaceutical Quality and Compliance Clinic Diagnostic 59

Imaging Technology

JANUARY 8, 2024

Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.

Healthcare 105

Healthcare Healthcare Radiation Oncology Radiation 105

Imaging Technology

NOVEMBER 2, 2023

After regional regulatory approvals, GE HealthCare plans to commercialize the models for use both in pharmaceutical drug development and for clinical decision support. These results are a promising development in the journey towards precision care, selecting treatment pathways based on the individual patient’s likely response.

Healthcare 59

Healthcare Healthcare Pharmaceutical Clinic 59

Imaging Technology

JULY 3, 2024

The rise of precision medicine is putting new pressures on diagnostic laboratories to tap into their pathology data, as whole slide images are among the best representations of disease. The same spatial mapping will also enable Nucleai’s applications to serve as companion diagnostics that match patients to the most effective treatment.

Pharmaceutical 59

Pharmaceutical Diagnostic Patient Care Clinic 59

Imaging Technology

JULY 25, 2024

Sarcopenia is an inevitable symptom of aging, and yet there are no pharmaceutical interventions to prevent or address the issue. Muscle atrophy is a leading contributor to falls, fractures, hospitalization, and comorbidities, accounting for more than $40 billion in annual health care costs in the United States alone.

MRI 104

MRI Pharmaceutical Disease Clinic 104